36 Background: Patients undergoing radical cystectomy have associated comorbidities 37 resulting in reduced cardiorespiratory fitness. Preoperative cardiopulmonary exercise 38 testing (CPET) measures including anaerobic threshold (AT) can predict major 39 adverse events (MAE) and hospital length of stay (LOS) for patients undergoing open 40 and robotic cystectomy with extracorporeal diversion. Our objective was to determine 41 the relationship between CPET measures and outcome in patients undergoing robotic 42 radical cystectomy and intracorporeal diversion (iRARC).
Introduction

71
The incidence of bladder cancer increases with age and is associated with smoking 72 and exposure to industrial carcinogens. Consequently, pre-morbid conditions that lead 73 to reduced performance status, such as cardiovascular disease, are apparent in the 74 treated population (1) . Radical cystectomy with urinary diversion remains the gold 75 standard treatment for muscle invasive bladder cancer and non-muscle invasive 76 disease in selected patients. Following radical cystectomy, the major adverse event 77 rate is around 15% and the 90-day mortality is between 1.7% and 9%, both of which 78 reflect the impact of surgery in a patient group with reduced performance status (2-4).
80
A number of methods exist to measure performance status with the intention to 81 predict post-operative adverse events and their use is recommended prior to major 82 surgery (5−8). Tools such as the American Society of Anaesthesiologists (ASA) 83 index, Charlson comorbidity index, Eastern Cooperative Oncology Group (ECOG) 84 performance index can be used to assign risk for major complication and mortality 85 following radical cystectomy. Another method, cardiopulmonary exercise testing 86 (CPET) has the distinct advantage of measuring the efficiency of physiological 87 oxygen exchange, and therefore cardiorespiratory function (CRF) for the individual 88 being tested. This allows clinicians to create a personalised risk profile with which to 89 predict post-operative morbidity and mortality (9,10). Systemic complications that 90 occur following major surgery arise in part as a result of the inability of patients with 91 poor CRF to meet the increased peri-operative oxygen demand which arises as a 92 result of a systemic inflammatory response (11,12). Measuring the peak oxygen 93 uptake (Peak VO2) during exercise, the threshold at which anaerobic respiration 94 begins to supplement aerobic respiration, the anaerobic threshold (AT), and the peak iRARC patients before cystectomy (median 34 days). Technical aspects of iRARC 119 have been previously described (16, 17 Urology from the UK NHS tariff for cystectomy using service line reporting.
139
Ventilatory equivalents at AT were calculated using standard methods (19). VO2 peak 141 was measured as the average VO2 attained over a 30 second period at peak exercise.
142
All CPET variables were determined on the day of the test and then independently 143 verified by a Consultant Anaesthetists with CPET expertise (RS). Data is presented as percentages or median with interquartile range (IQR).
169
Comparisons between independent groups were analysed using the non-parametric Table 1 . The median length of 184 stay was 10 days (IQR=6), there were 14 major complications within 30 days 185 (12.6%), and three deaths (2.70%) within 90 days, one cancer related (0.9%) and two No significant difference was found in AT, Peak VO2, or VE/VC02 (@AT) between 192 patients who had complications and those who did not (Table 3) . On multivariate 193 logistic regression analysis none of these CPET parameters were significant predictors 194 of a major complication at 30 days (Table 3 ). No significant correlation was found 195 between length of stay and either of AT, Peak VO2, or VE/VCO2 (@AT). Using 196 multivariate linear regression, CPET was not found to predict length of stay. (Table 3) 197 198
Previously, for cases undergoing ORC or eRARC an AT of 12 and 11 have been 199 defined as a threshold below which patients were at risk of increased LOS and 200 occurrence of major complication (14,15). Applying an AT threshold of 11 or 12, we 201 found no significant difference between patients above and below this threshold in 202 length of stay or major complications at 30 days. (Table 4) This is the first study to examine the relationship between cardiopulmonary 214 performance status and adverse events in patients undergoing iRARC. The results of 215 this prospective study in an unselected cohort of patients undergoing iRARC suggest 216 that in our population, the post-operative adverse event rate for major complications 217 following iRARC is 12.6%, which compares favorably to that described in previous 218 series (4). and AT=12) is highly predictive of major post-operative adverse events and LOS, we 222 found no significant relationship between CPET and these outcomes. We did find 223 weak association between CPET and hospital LOS but this was not significant, and to randomised trials of surgical technology, the feasibility of studies large enough to 280 detect differences in outcomes within in a defined group for e.g. poor 281 cardiopulmonary performance will be challenging.
In the knowledge that 282 cardiopulmonary performance status is an independent predictor of outcome in 283 ORC/eRARC but not iRARC it would therefore seem important account for this and 284 stratify cases according to performance status. For the present, the apparent lack of disadvantage for patients with low performance status can be included as part of the 286 shared decision making process in clinical practice. Competing interests 330 The authors declare that they have no competing interests. 
